Preventive and therapeutic effects of the selective Rho-kinase inhibitor fasudil on experimental autoimmune neuritis

Arnold Angelo M. Pineda, Motozumi Minohara, Nobutoshi Kawamura, Takuya Matsushita, Ryo Yamasaki, Xiaojia Sun, Hua Piao, Hiroaki Shimokawa, Jun Ichi Kira

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

We studied the effects of fasudil, a selective Rho-kinase inhibitor, on experimental autoimmune neuritis (EAN). Continuous parenteral administration of fasudil prevented the development of EAN induced by P0 peptide 180-199 in Lewis rats while it also reduced EAN severity when administered after disease onset. Immunohistochemical examination disclosed a marked decrease in the amount of inflammatory cell infiltration and attenuation of demyelination and axonal degeneration. Specific proliferation of lymphocytes from fasudil-treated rats in response to P0 peptide was significantly reduced as compared with those from phosphate-buffered saline (PBS)-treated rats. Fasudil treatment was associated with a significant reduction in secretion of IFN-γ; by contrast, secretion of IL-4 was almost the same in the fasudil- and PBS-treated groups. As a result, the IFN-γ/IL-4 ratio in the supernatant was significantly deceased in fasudil-treated rats compared with PBS-treated ones. Therefore, our results indicate a beneficial effect of selective blockade of Rho-kinase in animals with autoimmune inflammation of the peripheral nerves, and may provide a rationale for the selective blockade of Rho-kinase as a new therapy for Guillain-Barré syndrome.

Original languageEnglish
Pages (from-to)115-120
Number of pages6
JournalJournal of the neurological sciences
Volume306
Issue number1-2
DOIs
Publication statusPublished - 2011 Jul 15

Keywords

  • Experimental autoimmune neuritis
  • Guillain-Barre syndrome
  • IFN-γ
  • P0
  • Rho-kinase inhibitor

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Preventive and therapeutic effects of the selective Rho-kinase inhibitor fasudil on experimental autoimmune neuritis'. Together they form a unique fingerprint.

  • Cite this

    Pineda, A. A. M., Minohara, M., Kawamura, N., Matsushita, T., Yamasaki, R., Sun, X., Piao, H., Shimokawa, H., & Kira, J. I. (2011). Preventive and therapeutic effects of the selective Rho-kinase inhibitor fasudil on experimental autoimmune neuritis. Journal of the neurological sciences, 306(1-2), 115-120. https://doi.org/10.1016/j.jns.2011.03.031